Health Solutions Stocks List

Recent Signals

Date Stock Signal Type
2021-04-13 BRP Narrow Range Bar Range Contraction
2021-04-13 BRP NR7-2 Range Contraction
2021-04-13 BRP NR7 Range Contraction
2021-04-13 BRP New Uptrend Bullish
2021-04-13 ENDP NR7 Range Contraction
2021-04-13 ENDP Narrow Range Bar Range Contraction
2021-04-13 ENDP Lower Bollinger Band Walk Weakness
2021-04-13 MRK Bollinger Band Squeeze Range Contraction
2021-04-13 MRK 20 DMA Resistance Bearish
2021-04-13 MTEX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-13 MTEX Stochastic Sell Signal Bearish

Recent News for Health Solutions Stocks

Date Stock Title
Apr 13 ENDP Endo to Announce First Quarter 2021 Financial Results
Apr 13 ENDP Endo Announces Publication of Phase 3 Qwo® (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery
Apr 13 AMWL SPAC Alkuri Global gains on report of plans to take web doctor Babylon public
Apr 13 MRK 10 Best Stocks to Buy in 2021 According to Billionaire D.E. Shaw
Apr 13 AMWL Will Amazon Move Into the Telehealth Space?
Apr 12 MRK I’d still trust vaccines to suppress emergence of more variants: Doctor
Apr 12 MRK Merck (MRK) is a Top Dividend Stock Right Now: Should You Buy?
Apr 12 ENDP ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba® (dalbavancin hydrochloride) in Canada
Apr 10 MRK 6 Pet Stocks And An ETF For National Pet Day
Apr 10 MMS Maximus, Inc.'s (NYSE:MMS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Apr 9 MRK Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’ : Doctor
Apr 9 MRK Sanofi confirms partial response for cancer therapy in mid-stage study
Apr 9 MRK Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study
Apr 9 MRK Organon Announces Pricing of Senior Notes Offering
Apr 8 MRK Study shows wearables could detect COVID-19 earlier
Apr 8 MRK Merck & Co. Is Flatlined But Watch For Its Revival
Apr 8 MRK Merck’s Keytruda succeeds in late-stage trial as monotherapy in kidney cancer
Apr 8 MRK Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer
Apr 8 MRK Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Disease-Free Survival (DFS) Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC) Following Surgery
Apr 8 MRK Influencers with Andy Serwer: Gerald Chertavian